---
schema_version: "secwatch.filing_event.v1"
accession: "0001826466-22-000149"
form_type: "8-K"
ticker: "NIKA"
cik: "0001145604"
company_name: "NIKA PHARMACEUTICALS, INC"
filed_at: "2022-11-15T23:59:59+00:00"
generated_at: "2026-06-21T18:05:31.206552+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Appoints Dr. Darena Stoykova Zlateva as Chief Scientific Officer effective Nov 12, 2022

## Summary
- Dr. Zlateva appointed CSO of Nika Pharmaceuticals effective Nov 12, 2022.
- She holds a PhD in Immunology and a medical degree; prior roles at Sofia Medical Academy and European Medical Association.
- Employment contract signed with Nika Europe Ltd., in which Nika owns a 40% stake.
- CSO will manage research projects, represent company at scientific forums, and formulate long-term research strategy.

## SEC filing metadata
- accession: 0001826466-22-000149
- form_type: 8-K
- ticker: NIKA
- cik: 0001145604
- company_name: NIKA PHARMACEUTICALS, INC
- filed_at: 2022-11-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000149/0001826466-22-000149-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000149/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826466-22-000149
- JSON: https://secwatch.observer/filing/0001826466-22-000149.json
- Plain text: https://secwatch.observer/filing/0001826466-22-000149.txt

## Key facts
- Executive change
  Dr. Darena Stoykova Zlateva was appointed as Chief Scientific Officer at NIKA PHARMACEUTICALS, INC.
  - Action: appointed
  - Role: Chief Scientific Officer
  source text: On November 12, 2022, Nika Pharmaceuticals, Inc. (the “company”) appointed Dr. Darena Stoykova Zlateva as the company’s Chief Scientific Officer (“CSO”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000149/0001826466-22-000149-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.